Listen closely. These comments refer to possible FDA approvals of a drug candidate from Nanoviricides.
With respect to Dengue, I am suspicious that NNVC will be able to beat AVII and several other companies that are ahead of the drug development process.
With respect to HIV, I am suspicious as the FDA approval process requires phase 1, phase 2 and phase 3 testing that will take one hundred million dollars and more than 5 years of time.
Approval in the United States is critical to build value for the company. If you are suggesting approval in another country, I am not interested, nor is anyone else.